Drug Profile
QW 7437
Alternative Names: QW7437; SonoGenLatest Information Update: 04 Apr 2008
Price :
$50
*
At a glance
- Originator Sonus Pharmaceuticals
- Class Contrast media; Fluorocarbons
- Mechanism of Action Ultrasonography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Myocardial infarction
Most Recent Events
- 04 Apr 2008 Discontinued - Phase-I for Myocardial infarction (diagnosis) in USA (Parenteral)
- 15 Mar 2000 Phase I clinical trials have been completed
- 18 Jun 1999 Phase-I clinical trials for Myocardial infarction (diagnosis) in USA (Parenteral)